Anneli Hotti’s research while affiliated with Helsinki University Central Hospital and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (5)


Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts
  • Article

August 2011

·

23 Reads

·

18 Citations

Experimental Cell Research

Kristiina Järvinen

·

Anneli Hotti

·

·

[...]

·

c-Myc is known to induce or potentiate apoptotic processes predominantly by triggering or enhancing the activity of caspases, but the activation mechanisms of caspases by c-Myc remain still poorly understood. Here we found that in MycER™ rat fibroblasts the activation of c-Myc led to an early activation and cleavage of the initiator caspase-8, and concurrent processing and activation of the effector caspases 3 and 7. Interestingly, the expression of cellular FLICE inhibitory protein (c-FLIP) mRNA and the encoded protein, c-FLIP(L), a catalytically inactive homologue of caspase-8, were down-regulated prior to or coincidently with the activation of caspase-8. Of the other known initiators, caspase-9, involved in the mitochondrial pathway, was activated/processed surprisingly late, only after the effector caspases 3/7. Further, we studied the potential involvement of the Fas- and tumor necrosis factor receptor (TNFR)-mediated signaling in the activation of caspase-8 by c-Myc. Blocking of the function of these death receptors by neutralizing antibodies against Fas ligand and TNF-α did not prevent the processing of caspase-8 or cell death. c-Myc was neither found to induce any changes in the expression of TNF-related apoptosis inducing ligand (TRAIL) or its receptor. These data suggest that caspase-8 does not become activated through an extrinsic but an "intrinsic/intracellular" apoptotic pathway unleashed by the down-regulation of c-FLIP by c-Myc. Moreover, ectopic expression of c-FLIP(L) inhibited the c-Myc-induced apoptosis.



Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc

May 2003

·

74 Reads

·

37 Citations

The International Journal of Biochemistry & Cell Biology

c-Myc is an oncogenic transcription factor involved in the regulation of cell proliferation, differentiation and apoptosis. The direct targets of c-Myc mediating these various processes are slowly being unravelled. This study indicates that the ornithine decarboxylase (ODC) gene is a physiological transcriptional target of c-Myc in association with induction of cell proliferation and transformation, but not with induction of apoptosis. In addition to the two conserved CACGTG c-Myc-binding sites in the first intron, the CATGTG motif in the 5'-flanking region of the murine odc is also shown to be a functional c-Myc response element. odc is thus a c-Myc target with three binding sites a distance apart. Transient transfection studies with different c-Myc, Max and Mad constructs in COS-7 cells showed that the balance between c-Myc/Max, Max/Max and Max/Mad complexes is crucial for the regulation, resulting in either transactivation or transrepression of an ODC-CAT reporter gene. Transcription of both ODC-CAT and endogenous odc was strongly induced in HeLa cells expressing tetracycline-regulated c-Myc, concomitant with c-Myc promoting the S-phase entry of the cells. Transformation of NIH3T3 cells by c-Ha-ras-(Val12) oncogene was reversed by expression of transcriptionally inactive c-Myc, which was associated with repression of ODC-CAT expression. Further, the c-Myc-induced transactivation of ODC-CAT in COS-7 cells was suppressed by co-expression of the retinoblastoma tumor suppresser pRb, evidently as a result of pRb directly or indirectly interacting with c-Myc. Importantly, the endogenous c-Myc and pRb proteins were also found to associate in Colo 320HSR cells under physiological conditions. These results suggest that c-Myc and pRb can interact in vivo, and may in part control some aspects of cell proliferation and transformation through modulation of odc expression.


Figure 2 ATM is proteolysed in apoptosis. (a) Rat-1 MycER TM cells starved in 0.5% FCS for 24 h were treated with or without OHT (+/7) for the indicated times. Total cell lysates were subjected to Western blot analysis of ATM protein. Asterisk (*) denotes the intact protein and the cleavage products are indicated by arrows. Sizes of molecular weight markers are shown on the left. (b) Rat-1 ®broblasts were incubated without (7) or with (+) 0.5 mM staurosporine for 4 h, whereafter total cell lysates were analysed for the ATM cleavage by immunoblotting. (c) HL-60 cells were treated with (+) or without (7) 1 mM staurosporine for 2 or 6 h and total cell lysates were subjected to Western blot analysis of ATM. (d) The cleavage of PARP in staurosporine treated HL-60 cells is shown to verify the apoptotic status of the cells. (e) Rat-1 MycER TM cells were grown as described in (a) in the presence or absence of the caspase inhibitor Z-VAD (100 mM, 24 h) and total cell lysates were subjected to Western blot analysis of ATM protein  
Figure 3 Recombinant human ATM is cleaved by caspases 3 and 7. (a) Puri®ed recombinant human ATM was incubated in the absence or presence of the indicated recombinant, active caspases (0.5 mg of each) for 20 min at 378C as described in Materials and methods. The reaction products were resolved on SDS ± PAGE, and ATM and its cleavage products were detected by immunoblotting with the anti-ATM AHP392 antibody. Asterisk (*) denotes the intact ATM protein and the cleavage products are indicated by the arrow. (b) Testing the activities of the recombinant caspases 6 and 8 towards their known substrates. The activity of caspase-6 was checked by a speci®c cleavage of lamin A in isolated HeLa cell nuclei incubated in the presence of the recombinant caspases (Orth et al., 1996). The reaction products were solubilized in Laemmli sample bu€er and subjected to Western blot analysis with antibodies to lamin A+B2. To verify the caspase-8 activity, the recombinant enzyme was incubated with HeLa cell cytosolic extracts (or recombinant caspase-3), and the samples were then analysed for the cleaved proteins by immunoblotting with antibodies to caspase-3 (or Bid, data not shown)  
Figure 4 Expression of recombinant human ATM in Rat-1 MycER TM cells protects in part against c-Myc-induced apoptosis. (a) Rat-1 MycER TM cells were transfected with an episomal expression vector carrying a FLAG-tagged, full-length human ATM cDNA and hygromycin resistance marker. As a control, cells were transfected with the empty vector. After selection of stable transfectants, the populations of surviving cells were cultured with or without OHT (+/7) for the indicated times, and apoptosis was scored by counting the number (percentage) of dead, detached cells in a Coulter counter. The results are shown as means (+) standard deviation of three or four independent experiments at both the indicated times. It is notable that, the protective e€ect of ATM against the c-Myc-induced apoptosis was also found at the other points analysed, i.e. at the earlier (24 ± 30 h) and later (72 h) phases of apoptosis. (b) The stable populations of the transfected cells were subjected to Western blotting analysis of the recombinant ATM protein. Total protein were separated by SDS ± PAGE and blotted with monoclonal anti-FLAG M2 antibody  
Figure 5 Apoptosis induced by c-Myc is accompanied by a loss of mitochondrial transmembrane potential. To measure mitochondrial transmembrane potential the Rat-1 MycER TM cells were exposed to the mitochondria-speci®c DioC 6 (3)-dye and its incorporation was analysed by FACS. (a) Rat-1 MycER TM cells were starved in 0.5% FCS (24 h) and cultured without 4- hydroxytamoxifen (OHT) (dark grey) or with OHT (light grey), or with both OHT and the caspase-inhibitor Z-VAD for 24 h (white), whereafter the uptake of DioC 6 (3) was determined. (b) Incorporation of DioC 6 (3) into cells grown in 5% FCS (control, with normal membrane potential) (light grey) or into cells treated with the uncoupling agent mCICCP (membrane potential lost) (white)  
Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases
  • Article
  • Full-text available

June 2000

·

115 Reads

·

60 Citations

Oncogene

The mechanism(s) of c-Myc transcription factor-induced apoptosis is still obscure. The activation of c-Myc has been found to lead into the processing/activation of caspases (caspase-3), but the significance of this for the cell demise is debatable. Here we report that several targets of caspases (PKCdelta, MDM2, PARP, replication factor C, 70 kDa U1snRNP, fodrin and lamins) are cleaved during c-Myc-induced apoptosis in Rat-1 MycER cells, indicating an important role for caspases in the apoptotic process. We further found that the ATM (ataxia telangiectasia mutated)--protein is a novel key substrate of caspases. In in vitro assays, purified recombinant ATM protein was found to be cleaved by the effector caspases 3 and 7. The functional significance of the ATM cleavage is supported by the finding that ectopic expression of ATM protected in part against apoptosis. We also show that c-Myc-induced apoptosis involves loss of mitochondrial transmembrane potential, release of cytochrome c from mitochondria into the cytosol and subsequent processing of caspase-9. The cleavage of caspase-9 is, however, minimal and a much later event than the processing/activation of caspase-3, suggesting that it is not the apical caspase. Evidence is provided that there is, nevertheless, an upstream caspase(s) regulating the functions of caspase-3 and mitochondria. Additionally, it was found that p53 becomes upregulated, together with its transcriptional targets MDM2 and p21, upon c-Myc induction, but this occurs also at a later time than the activation of caspase-3.

Download

Citations (4)


... Previous research has demonstrated a strong correlation between the occurrence and progression of various diseases and apoptosis, with Myc being frequently overexpressed and mutated [21,22]. Studies have revealed that the expression of Myc initiates a series of apoptotic processes by stimulating caspase activity [23]. Caspase 3, an apoptotic effector, has been found to undergo cleavage into active subunits during the early stages of Myc-induced apoptosis [24]. ...

Reference:

Vibrio splendidus infection promotes circRNA-FGL1-regulated coelomocyte apoptosis via competitive binding to Myc with the deubiquitinase OTUB1 in Apostichopus japonicus
Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts
  • Citing Article
  • August 2011

Experimental Cell Research

... For example, in cells transfected with 2 g c-Myc, the number of cells with morphological signs of apoptosis, as assayed by nuclear DNA staining with DAPI, was increased from about 10 to 40% after 2 days of low serum culture. In concert with these data, we have found (by cDNA microarray and Northern blot analyses) that induction of Myc in Rat1A MycER and Rat 1 MycER TM cells grown in the presence of 0.5% serum (under the apoptotic conditions) does not result in an increase in ODC mRNA expression, while in the presence of 10% serum the levels of ODC mRNA are increased several fold (Hotti, 2000;Kangas, Nicholson, & Hölttä, 1998;Järvinen et al., unpublished data). A clear, dose-dependent induction of odc transcription by c-Myc was also detected using theFig. ...

Caspases in c-Myc-induced apoptosis /
  • Citing Article

... As, Cyt c is the master regulator gene encoding the transcriptional factor that is implicated in the regulation of apoptosis, cell proliferation, and transformation (Rashad et al. 2018). Cyt c activation leads to the activation of CASP 3, which is considered the main executor of apoptosis and chromatin condensation (Hotti et al. 2000). Therefore, LTZ administration led to upregulation in the gene expression of CASP-3 (an apoptotic marker) and was confirmed by an exaggerated immune reaction to it upon immunohistochemical staining of both hepatic and renal tissues. ...

Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases

Oncogene

... 37 On the other hand, it seemingly contradicts findings in MYCN-amplified neuroblastoma and DIPG preclinical models that show that MYCN-expressing cells, that have high levels of ODC1, are more addicted to polyamines and thus more sensitive to polyamine biosynthesis inhibition. 12,13,35,53,54 The discerned relationship between elevated expression of polyamine transporters at baseline and after DFMO treatment, and suppressed sensitivity to DFMO, as well as the observation of higher uptake rates in the least DFMO-sensitive cell line versus the most F I G U R E 6 Polyamine depletion slows progression of KMT2Arearranged infant leukaemia models. (A) Design of the in vivo study for the PER-485 xenograft model. ...

Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc
  • Citing Article
  • May 2003

The International Journal of Biochemistry & Cell Biology